<!DOCTYPE html><html lang="en-US"><head><title>Just a moment...</title><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta http-equiv="X-UA-Compatible" content="IE=Edge"><meta name="robots" content="noindex,nofollow"><meta name="viewport" content="width=device-width,initial-scale=1"><style>*{box-sizing:border-box;margin:0;padding:0}html{line-height:1.15;-webkit-text-size-adjust:100%;color:#313131;font-family:system-ui,-apple-system,BlinkMacSystemFont,Segoe UI,Roboto,Helvetica Neue,Arial,Noto Sans,sans-serif,Apple Color Emoji,Segoe UI Emoji,Segoe UI Symbol,Noto Color Emoji}body{display:flex;flex-direction:column;height:100vh;min-height:100vh}.main-content{margin:8rem auto;max-width:60rem;padding-left:1.5rem}@media (width <= 720px){.main-content{margin-top:4rem}}.h2{font-size:1.5rem;font-weight:500;line-height:2.25rem}@media (width <= 720px){.h2{font-size:1.25rem;line-height:1.5rem}}#challenge-error-text{background-image:url(data:image/svg+xml;base64,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);background-repeat:no-repeat;background-size:contain;padding-left:34px}@media (prefers-color-scheme:dark){body{background-color:#222;color:#d9d9d9}}</style><meta http-equiv="refresh" content="390"></head><body class="no-js"><div class="main-wrapper" role="main"><div class="main-content"><noscript><div class="h2"><span id="challenge-error-text">Enable JavaScript and cookies to continue</span></div></noscript></div></div><script>(function(){window._cf_chl_opt={cvId: '3',cZone: "nelloehrback.onrender.com",cType: 'managed',cRay: '912fecafce3dcd80',cH: 'QonEaGeiMtComhyns_9QWPpTyBdAVWyCn5pvpBzMXNU-1739733936-1.2.1.1-65YiEDmmkvtGD8YqeYzQni128C5rW_x9y7OSDF1GxFzmF1CArayr_a8myOEQj7ul',cUPMDTk: "\/api\/drugs\/fetch\/generic-names?__cf_chl_tk=qNseyorwXEd.ixQKIr8uGDSEHZk40uC5zT4y9tcBycA-1739733936-1.0.1.1-mneqrpFoYuwA0D6J1VWHmYF4t8s2JMmGyN4XXo2ZyRc",cFPWv: 'b',cITimeS: '1739733936',cTTimeMs: '1000',cMTimeMs: '390000',cTplC: 0,cTplV: 5,cTplB: 'cf',cK: "",fa: "\/api\/drugs\/fetch\/generic-names?__cf_chl_f_tk=qNseyorwXEd.ixQKIr8uGDSEHZk40uC5zT4y9tcBycA-1739733936-1.0.1.1-mneqrpFoYuwA0D6J1VWHmYF4t8s2JMmGyN4XXo2ZyRc",md: "OKMrKU.0bHTzFVNpyUN7sskoQ91sLjNfShd5TC5.Zz4-1739733936-1.2.1.1-j1w1lMHzzg4pnwfvgri86i1_NlnUox8Mk9GwTMy6pJJzzBAmOxrBoUhCb85thaCyxj995vKn3tQQWBjKkVl4SOCT95Abm7lYCh11j_0geWWzX8tfOP2NL8J4Zj7pU5OCoArWGj75mXnz3uJyFv05f9PY7aesiJL8xi58zJX7cA0HuEjvI4nhFXSnBxp2EFZAzEijGmCt9udfsOKq7lWfxi2lx_wGUB7WiQwwSQj6lVJzSt2W5U4JlK5jOxBUy1OqAReU4QleOezqZ92BnWxQUUpDHhHBJN4xiUxkMwVP3GVAkezv8enuIyWlCXAs.tNiiVQgnW6mnC.Cct2oeBJvYs9b1yQ2AIndrtBQtKGM85fiJLSJ8Hjo1z1_oV727q7xwSIdzjuLVg5E.460QuHqIREYyrhBi.XkQB_DSW4fUKl_8vupGocyWGqAAAyuQLr81yntFngnFN5_N4zc08M1pW_MjA_DsUcLU7cESvz58bdc8GPnn7Y4w4wsru.VDwwuy3BsOgLXWyYqpA86_Dyf4qn8aI4Vsd1YDCp92KTOT.RRRpBAqqXJzci9TMEvp673JWjNB.PGOGrUrCcJxIyiWmy2DNnIHG3TEYH_kWFpDw2cHDSgLHXDdQNh1PUIFvH4Fm49HnSGM8NgZXT.iAN95eAGprnYz3EHO6fyOtpNV3D60ktyw9h8SW3caUNfbHQZvNpZ5gCOi904B5fOvR6ueUrTmHZ9qEf6vf78.nXP8TaTG9wWkzP8K2Fz6BRJJNErpPj1qA7pkjLNVXecVcMKsR8KKiaJLuw9Djv1mmHn_.AB4z14XYX1Smk01STOq0x7PpOCDRspOxmFLgMFIbZ04Kpd01xwvSDaigMLQhxg0oDIF4zpvMdET4MscyYHlsn_J.4APrStEE4PaOc5iOA3xtcSwFqEa6ndaLQjngdWisXdbeYTWIAtGn2dWCH0Uz1UrGeUtwWJjqeubhvk1AHHD28GA9rpNjYKHfOWQ.cDWxU2i5kVOsTuk_rpFMzW9lw29y7.hPgygPccNCYWwuTY_YAr5.D.1A_qkdpNVKPMnMN7iPe9fcHeXxpb_7vQNU3tFdiCkIOjEjF0B7QTTVLmCwrA68LNP54nEQpvUB0kaeZqUAvYRso38Pmc50KXXyCR8eflYKDxKOX5fZ_ewHqw.qARWQxNJpkp3CM6.BIBR7ztQ_9xjtSHPs3p5RRPmpz7qi1Ro2k6xTSULJ_Ndsz0peDpIxq_ZqJWOp725K4D8oF1srxpB9g3QR3KPyORgqVppsB9g0HkebY9kg9Wp.RH8lU2Mjc3p_4dR8G4yGqqCFptDnB92bGrcm.0H5T6RKzYO.MgOS1g1Q7XBIwudXM6TeJ3kMsUCAxWoHi5yPbLjUJbaa_i1OlTbZLpyCu3fVM1MAGx6A03eYH42TjVy8e85.vhKUvJefQ638mS.zL8cx4Pd6u_rafkfXOIQtUJi7hmeK3XPBnh18IqDN_uc2XxWIiMqnig3pZoKQRemwYfw2lICKOoyjFLe9kkto.jLH_FnQYWUNwRsFh18gXUPyBV5WZs8iBc8pTZqLbFfHCC9s9HQLqRYhcY2jmh9rGTAyeMHKpDSXv66nIddzwtm86bTk8iX8bwjsVu1VUaF8RdL1JcmgbLPze9juU5v4wrTvZ3FuWiL1XRDIEUi89wdv0vXUw70IUKr37.hzhWxFiRxy5QUtPWa3gztySTDHB3KCNhehbOxe9Rj4eqKBOi0EVCeAMjAoGTgvebVMCJ8lvOkRXMFRWJvnGwU8NkbUYUwH5YTCr5aZ_iqkbWXazFVq.23AKvBOt44DGcDG_.YolTS.mmI81bdiW3wa_HVl85GxdDlsI0inHAuKczQO_IGhmCImm4qZpseSUJrt8_9wdiXprDYV5xO7Chj7hoDGi.qhTLJYIxHKlr3kCDuVxSys0JQ2J2QcwRWk0LLPDdybFGDMLn9wjSUOMmHpnkWYXq1PSL9iF_S_.LhP1h4oNpnod4KgeeJPzPdOcDxF6zOGFEn2VyIim_rgN9vDMT2rKPayA6eDGDLGXJu8h3_r4zZ.r5rjBdJ9LpgM425kk3fBxAwUD1Vfn997ymk2guySR9R40oRFZF2uxaUbReNz2tXnU9SISv1Sa2bHX03C5izIgvEqAhHfz8LMUv14IMgSFo2NRJucfn1I8c3huT3uVG2bemgRUbV5kilhXwF340fYarm.RgtBXu6FndMleKaGGcV73uo.jguUM_PLELgXtrdhKPuxEvJs7eROae1KDvrJOydgOZ9AIre8IdoM4CBaWqHNo58dYlDEXG29ZNN43olP5nK6kFacCwx2ohDV8u5g.PLexlcdO2agK7txMdos6G3VYZiZY.IbL490d5_Gxi35aBjz3WLRUv1kcpTqgTZsy4KAI",mdrd: "Cerux517QkxMXWKYNR8kfxCXgpA4G_dBcW187nrhQuo-1739733936-1.2.1.1-C4krgcpJGw2b2e6wl4cg4xRAHH_q6tiP7rR42k0AcYRaS9RC228OyHCxGTWCFwboaop6DSz.gkEhawr3dfBYSSOSSm6EY_lBrjvxEKIZUJd_VI3zo5eJk3p2BQ7m4vECvK178fpoN4O9vtM8wnlVNwdfUHGIgFcdDvc.kZBL.H63ewuHz775IRjDXyElSPnxuaEPZL.2NlHPIvxnt.lQrntGA2xEm6ofeICE1EDqBR0u05CL6tWSxxVU8iFFP18tnUiosOjVPai7QQZzP56ZMfTA58HyJa_U9qveCj7KtzJWJLNu5p5wlx_yvwIfWt7jcQXdZfmkDqU.vOM72OFJs2N8iYUOzb7qYorr9fGSq8Crdp40EVPrQmBt.FSz7L2wnIxMTzFRdTrqSTdA3.HKjGoyux32qB8Aaj9f5FX6O1cM0DxxuL6KyhjdLJILcU91Rn658PMufeQ3AGAz5jJZ1Oiv08QF1V71B9MKAEwBARFgm9EtzD316wS8dSqfJPZe6IGhThvA66uogLiX6x.gqWCRVUEUxb9XK0RQAb64pLpHWZ9ac_qrNqxOssIHW9TZXx3VQwAiMAFMvcp67NaUcDJkJUIaodicNMQaAz5EWVjmRIDuqPT0PzpKhdcgdbNI3OdYArMq4qrt6ayCZI.yHiOBnJm4oeXzbU0DItA8LlDKnI6CXtpQT.7J6jUZjnYS5T0zPmsj5O.JdSJiCkH_RCKTHAkJMVqH7zWPN4Qk7fYWX1wdJLzZRbRKKNxh7yAn5fKRgR6M57Z_a0hrrslKk0VIVkSjrD0RQCNTJSTeH_K_eAGxXhU6ZPgUziCBqTVGNbT86x1sAfodoXSM5u24j1aGJ15F7iUu62FsiycYyn1dA.RfBxHlV1.0YbjrGaqWHqfAgX_RCR63nmxaRvBMnjFKEaoxIiF6bZjUEGZDeIijb9ozgMIVsMHDUmJpaNe2VoeKdOHIrvawUc1LM7RuZLDib7dJEpUtrdLTbhLZH04qogL1Xnrd3GtUEMfKmLZ6XIP466rYmhCQ7b4S3sTRDoEnjTPsQWTZ41_zfNtXNNo701Z8XXtVKu3uza8l7z9Hl3cFnPymC3WsXhMkCapACepFGdBSGFnFc0pHSANDQDLPOdksDbjOgkQHpttP7pX9aQBjWl_VurgjfBtejuG79MKVrS07phJ5NULm7z_4CQYaggr.9MwUCbr4iSyyu6eky2lGnGjNj_7YmCb3LAmWV1EPq2sp11vcQcfLr88NpzN_MYy5X9LIz3HuvSyMLS2igyr0E34zG_0dbHP5aDJgeJQFZcwppEPWbuleTlpGPkvJMsrhQIiTONYS6wLuhE4lkL.NgCtyilP5MQGPOHSqLCQqYGp2Mhxfw0AeNnWOvMXoV6M9GXxEThyqoBgT3CGGXvjumWyJw0d7LlXoXpi36q1G7NHprpI2655xqKcb15baKUQ.T8rOJekjCopH.8fI7J2coIJPCqGvfM_KhKKIHHvUmUI15G8xNxcESd2rV5Q7RaASYfRGGx4uc2QLFTuCVx7QK01MEUc9y6mXVqBgqm00geE2PtGD4OJqVJsa_RlfQijfhVhffTGFPMXAs3XJvO.8ADhDRo9p.1uks9_ldsMP.cqmXKcXmw37xwlutCt9WeZY45Tynf8bROHqiMllLWfB7hzfWoShSRvSgz8zzq_RVPK6Z1Vui6.QfTqmcyHcNYLcOREw3I2tuRkzW.JQWsKFq4hzQKrtWNTw4ZhhY1IfG6r56fIvESke8H5_4FVvX.oIA9nJcJbp2GhsqHeJgRWkO3cC6I_Vmta.rkUtGl3Do9abRtbKVZZCOymNL16UUTaDOwexvC9C32fpHU87KO3nivSqfCn9qnIsKqgq1C5OG9JcUvwD1hg5VFD0UhQRW94goUZDKCVnV8IVE9luQ_mPR4ozW6Vv7y9.ly2t28r6_jl_0CxStggdYoj0AbUs1tw2I3BUkzevEplOyPr9GfuUMk8TR0eO4ddHzz2cTGQilC.oTAXk1RvPDMNooxoMzO85yVIxJkKVUXSn8rzwnM_hTh3BKhNGutB8YjwILHYVEUg1mzS4Y_ECDOs4Gz1V63hrdAT5p6ObLphJHkjiIajju.epsa4c37VsTCrzTELuw9carontSRFKwTmMt9.7vVzpkMNM1WDSJv4mr78dZQXt4Vs9m2sGk4HLRk3fgEovNjqEzoYhqT7xLZXO9cCJRrKyT7d76wAz1VKqMO9A6AroRsX5F4phmqMJdmfF2wDkvTo1kBF7W3QF0avyK5bw8VxQMoV6DTSUP.bzoEKL8wiy7LYN.Lt6q9.._cUQDGbRWvmPpW_hNGiMUhVJy10JwX_XyfGXsv1zFyz522HGv3waSmRDytX4eReiuyWDxLUC4ywFpwcY6.XTDeGg6JoOd1AcnbWlSB6OBon_N43nP4SRqG1csLnChQFjf8p7NqW8UHlMd3j6KLJn6Yo8Fv2LQeIOB6qmz_NqtkEZojHymsB7l5Qn.dz6hRN5utxfJ7TvOvzNtdR.i7g78V9JD4cgGjQc4m34S7w0S7L_iLmfIqBMojXEzA8u_kGLs6RkQR2TrpxnYc_9Lf0XQQ.iOb4PNK.SRdVFV.IfnZZo3ir9Ct.bNJ_4FMN0XHworzoDPH6cZsquYcKKu4l09scf466_rfZI17wQZJUl21s0WRvHh8Pk319hC0S4P8n8xh_PYXlIWjk7yCZP.as_khkOMT8cGV.g_Yo1UhEBiVYWtRj0xl8bGy5BC.Uy7w0zKSDvGTpS1D_3rd2WX7odhjI6_aZDjD.UQLitfz88SDBanjQvobOCGZMf1q0ClfjtAmfN7FIBpG1UwoIlKEk9KTixEVxjFUk41_f3KJXoFPiMXzUS43Zs9JVKeuWRS7D9Y5uQys7THr0CO_nt0i.gezKOUElSigmdA91ZSWPXHe_n7ckKyQmvjkJ9AU0JqQyqMNq1j9QbnhL0Iwen6A2AIz21fhWxlBva7MEOf5o02M7ExfyUpn0mlByF0mShGw9APuvH2OWslURMPeVsCwP.HbJlTGZYarA8kUbekEjuHqDs00uu"};var cpo = document.createElement('script');cpo.src = '/cdn-cgi/challenge-platform/h/b/orchestrate/chl_page/v1?ray=912fecafce3dcd80';window._cf_chl_opt.cOgUHash = location.hash === '' && location.href.indexOf('#') !== -1 ? '#' : location.hash;window._cf_chl_opt.cOgUQuery = location.search === '' && location.href.slice(0, location.href.length - window._cf_chl_opt.cOgUHash.length).indexOf('?') !== -1 ? '?' : location.search;if (window.history && window.history.replaceState) {var ogU = location.pathname + window._cf_chl_opt.cOgUQuery + window._cf_chl_opt.cOgUHash;history.replaceState(null, null, "\/api\/drugs\/fetch\/generic-names?__cf_chl_rt_tk=qNseyorwXEd.ixQKIr8uGDSEHZk40uC5zT4y9tcBycA-1739733936-1.0.1.1-mneqrpFoYuwA0D6J1VWHmYF4t8s2JMmGyN4XXo2ZyRc" + window._cf_chl_opt.cOgUHash);cpo.onload = function() {history.replaceState(null, null, ogU);}}document.getElementsByTagName('head')[0].appendChild(cpo);}());</script></body></html>